Efficacy, Safety, and Patient-Reported Outcomes Across Young to Older Age Groups of Patients with Hr+/Her2-Advanced Breast Cancer Treated with Ribociclib plus Endocrine Therapy in the Randomized Monaleesa-2,-3, And-7 Trials
AuthID
P-017-ZR9
P-017-ZR9